Many pathophysiological cellular functions in aging and cancer involve SOCE and Orai3 [26,27,35,36,37,38,39,40], highlighting the importance of understanding the pharmacology of Orai1/Orai3 heteromeric SOCE channels. This evidence concerns the gene ORAI3 and cancer.